Clinical Trial Update: Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating methylphenidate to improve quality of life in patients undergoing radiation therapy for brain tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors
• Cognitive Functional Effects
• Fatigue
• Major Depressive Disorder
• Quality of Life

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Brain and Central Nervous System Tumors, Cognitive/Functional Effects | Phase 3 | Status: TERMINATED